Treatment Sequencing and Use of Biomarkers to Guide Treatment Selection in Bladder Cancer
1 Views
administrator
07/08/23
A roundtable discussion, moderated by Vadim Koshkin, MD, of the University of California, San Francisco, focused on treatment selection for different patient populations with advanced bladder cancer, including a discussion of new data presented at ASCO 2023. Dr. Koshkin was joined by a panel that included Matthew Zibelman, MD; Cora Sternberg, MD; and Daniel Petrylak, MD.
In the next segment of the roundtable series, the panel addresses treatment sequencing decisions following disease relapse, as well as the use of biomarkers to guide treatment decisions.
-
Category
Show more
Facebook Comments
![Actinic Keratosis Treatment and Cancer Potential - Eyelid, Face, and Neck [Dermatology Course 32/60]](https://i.ytimg.com/vi/ffcHWDpKZqQ/maxresdefault.jpg)
No comments found